Cargando…

Genetic insights into breast cancer risk

Detalles Bibliográficos
Autores principales:	Wong-Brown, Michelle, Avery-Kiejda, Kelly, Scott, Rodney J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565572/ http://dx.doi.org/10.1186/1897-4287-13-S1-A1

Ejemplares similares

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

Overview of genetic markers for hereditary colorectal cancer
por: Scott, Rodney J
Publicado: (2012)

Novel genes associated with lymph node metastasis in triple negative breast cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

Genome-wide miRNA, gene and methylation analysis of triple negative breast cancer to identify changes associated with lymph node metastases
por: Avery-Kiejda, Kelly A., et al.
Publicado: (2017)

Verification and Validation of a Four-Gene Panel as a Prognostic Indicator in Triple Negative Breast Cancer
por: Pariyar, Mamta, et al.
Publicado: (2022)

Genetic variants of CYP19 (aromatase) and breast cancer risk
por: Nedelcheva Kristensen, V, et al.
Publicado: (2000)

The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer
por: Avery-Kiejda, Kelly A, et al.
Publicado: (2014)

Copy number variation in triple negative breast cancer samples associated with lymph node metastasis()()
por: Pariyar, Mamta, et al.
Publicado: (2021)

The curious case of a woman with two BRCA1 mutations in trans
por: Scott, Rodney J, et al.
Publicado: (2015)

DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients
por: Mathe, Andrea, et al.
Publicado: (2016)

A novel polymorphic repeat in the upstream regulatory region of the estrogen-induced gene EIG121 is not associated with the risk of developing breast or endometrial cancer
por: Bolton, Katherine A., et al.
Publicado: (2016)

Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer
por: Avery-Kiejda, Kelly A, et al.
Publicado: (2014)

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression
por: Steffens Reinhardt, Luiza, et al.
Publicado: (2023)

Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients
por: Chatterjee, Gaurav, et al.
Publicado: (2018)

Arsenic (As) and breast cancer risk
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Zinc and breast cancer risk
por: Kaczmarek, Katarzyna, et al.
Publicado: (2012)

Folic acid and breast cancer risk
por: Durda, Katarzyna, et al.
Publicado: (2012)

Selenium (Se) and breast cancer risk
por: Jaworska - Bieniek, Katarzyna, et al.
Publicado: (2012)

Comparison of the QuantiGene 2.0 Assay and Real-Time RT-PCR in the Detection of p53 Isoform mRNA Expression in Formalin-Fixed Paraffin-Embedded Tissues- A Preliminary Study
por: Morten, Brianna C., et al.
Publicado: (2016)

Chromosomal instability and cancer predisposition: insights from studies on the breast cancer susceptibility gene BRCA2
por: Venkitaraman, A
Publicado: (2001)

Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis
por: Sawyer, S, et al.
Publicado: (2012)

Molecular analyses of human breast cancer metastasis: genetic markers of progression
por: Driouch, K, et al.
Publicado: (2000)

A polymorphic repeat in the IGF1 promoter influences the risk of endometrial cancer
por: Bolton, Katherine A, et al.
Publicado: (2016)

Heterocyclic amines (HCAS) and risk of breast cancer
por: Sinha, R, et al.
Publicado: (2001)

GWAS markers in diagnostics of breast cancer risk
por: Jakubowska, Anna
Publicado: (2012)

Rapid test for detection of high risk of breast cancer
por: Durda, K, et al.
Publicado: (2012)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
por: Jaworska, Katarzyna, et al.
Publicado: (2012)

Risk-reducing surgery for breast and ovarian cancer risks - where are we now?
por: Hallowell, N, et al.
Publicado: (2012)

An intraductal approach to breast cancer risk assessment and screening in a diverse population
por: Bailey, L, et al.
Publicado: (2009)

Switching off Cancer: Is There a Role for Epigenetics?
por: Avery-Kiejda, Kelly A.
Publicado: (2021)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

Organochlorines and breast cancer: effect of exposure to dieldrin on risk and survival
por: Høyer, AP, et al.
Publicado: (2001)

New diagnostic test for high risk of breast cancer in Poland
por: Gorski, B
Publicado: (2011)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer
por: Huzarski, T T, et al.
Publicado: (2012)

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet
por: Lubiński, J, et al.
Publicado: (2012)

Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
por: Ferrucci, PF, et al.
Publicado: (2000)

Validation study of risk prediction models for female relatives of Australian women with breast cancer
por: MacInnis, R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2v8kdbd4t150aistc12dcbfite